Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shreyaskumar Patel

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Cancer|April 22, 2006
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rulesKenneth V I Rolston, Ellen F Manzullo, Linda S Elting, et al.
Sarcoma|September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"Edwin Choy, Karla Ballman, James Chen, et al.
Journal of Neurosurgery. Spine|February 21, 2015
Giant cell tumors of the spine: has denosumab changed the treatment paradigm?Tony Goldschlager, Nicolas Dea, Michael Boyd, et al.
The Canadian Journal of Cardiology|August 21, 2017
Progressive and Reversible Conduction Disease With Checkpoint InhibitorsNeeti Reddy, Rohit Moudgil, Juan C Lopez-Mattei, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcomaCamilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
American Journal of Clinical Oncology|January 8, 2019
Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and SurgeryAndrew J Bishop, J Andrew Livingston, Dejka M Araujo, et al.
Cancer|September 28, 2007
Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patientsPaul M Armistead, Jason Salganick, Jae S Roh, et al.
Bioinformation|March 30, 2026
Impact of gut microbiota on human immune system development: A longitudinal studyDipalben Shreyaskumar Patel, Mukul Singh, Vivekanand Ashok, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Cancer|April 22, 2006
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rulesKenneth V I Rolston, Ellen F Manzullo, Linda S Elting, et al.
Sarcoma|September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"Edwin Choy, Karla Ballman, James Chen, et al.
Journal of Neurosurgery. Spine|February 21, 2015
Giant cell tumors of the spine: has denosumab changed the treatment paradigm?Tony Goldschlager, Nicolas Dea, Michael Boyd, et al.
The Canadian Journal of Cardiology|August 21, 2017
Progressive and Reversible Conduction Disease With Checkpoint InhibitorsNeeti Reddy, Rohit Moudgil, Juan C Lopez-Mattei, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcomaCamilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
American Journal of Clinical Oncology|January 8, 2019
Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and SurgeryAndrew J Bishop, J Andrew Livingston, Dejka M Araujo, et al.
Cancer|September 28, 2007
Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patientsPaul M Armistead, Jason Salganick, Jae S Roh, et al.
Bioinformation|March 30, 2026
Impact of gut microbiota on human immune system development: A longitudinal studyDipalben Shreyaskumar Patel, Mukul Singh, Vivekanand Ashok, et al.
Pageof 12